date:Feb 08, 2014
intends to earn 30% of its revenues in these domains in five years' time.
This growth ambition is underscored by two recent acquisitions:
In December 2013, Lesaffre acquired Omniabios, an Italian company with specific expertise in purifying the S-Adanosyl-L-methionine molecule (or SAMe). SAMe is a natural product of the human body, and used to produce other molecules, including hormones, proteins, brain chemical messengers, and natural antioxidants.
As a food supplement, it is primarily used